Want to see EBS full AI Analyst Report?
Emergent Biosolutions (EBS) Ownership Overview
5.35% Insiders
17.76% Mutual Funds
13.40% Other Institutional Investors
28.10% ETFs
35.40% Public Companies and
Individual Investors
The ownership structure of Emergent Biosolutions (EBS) stock is a mix of institutional, retail, and individual investors. Approximately 59.26% of the company’s stock is owned by Institutional Investors, 5.35% is owned by Insiders, and 35.40% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 09, 2025 | xxxxxxxxxxxxx | $262952 | |
Aug 13, 2025 | xxxxxxxxxxxxx | $67772 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $180941 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $1355490 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $87068 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,013,707 | Institution | 5.88% | 17,811,008 | |
| 2,754,926 | Institution | 5.37% | 16,281,613 | |
| 2,686,082 | Institution | 5.24% | 15,874,745 | |
| 2,201,930 | Institution | 4.29% | 13,013,406 | |
| 2,057,758 | Institution | 4.01% | 12,161,350 | |
| 1,500,658 | Institution | 2.93% | 8,868,889 | |
| 1,113,338 | Institution | 2.17% | 6,579,828 | |
| 1,027,579 | Institution | 2.00% | 6,072,992 | |
| 889,337 | Institution | 1.73% | 5,255,982 | |
| 829,152 | Institution | 1.62% | 4,900,288 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,201,930 | Institution | 4.29% | 13,013,406 | |
| 1,500,658 | Institution | 2.93% | 8,868,889 | |
| 889,337 | Institution | 1.73% | 5,255,982 | |
| 588,168 | Institution | 1.15% | 3,476,073 | |
| 495,984 | Institution | 0.97% | 2,931,265 | |
| 465,318 | Institution | 0.91% | 2,750,029 | |
| 330,315 | Institution | 0.64% | 1,952,162 | |
| 316,030 | Institution | 0.62% | 1,867,737 | |
| 301,075 | Institution | 0.59% | 1,779,353 | |
| 159,609 | Institution | 0.31% | 943,289 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,773,734 | Institution | 5.41% | 16,475,980 | |
| 1,830,923 | Institution | 3.57% | 10,875,683 | |
| 1,554,116 | Institution | 3.03% | 11,220,718 | |
| 1,374,840 | Institution | 2.68% | 8,125,304 | |
| 593,944 | Institution | 1.16% | 4,288,276 | |
| 545,815 | Institution | 1.06% | 3,242,141 | |
| 509,557 | Institution | 0.99% | 3,026,769 | |
| 498,167 | Institution | 0.97% | 2,944,167 | |
| 361,880 | Institution | 0.71% | 2,138,711 | |
| 306,396 | Institution | 0.60% | 1,819,992 |
FAQ
Who Owns Emergent Biosolutions (EBS)?
According to the latest TipRanks data, approximately 13.40% of the company's stock is held by institutional investors, 5.35% is held by insiders, and 35.40% is held by retail investors.
What percentage of Emergent Biosolutions (EBS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.40% of Emergent Biosolutions (EBS) stock is held by institutional investors.
What percentage of Emergent Biosolutions (EBS) stock is held by retail investors?
According to the latest TipRanks data, approximately 35.40% of Emergent Biosolutions (EBS) stock is held by retail investors.
Who owns the most shares of Emergent Biosolutions (EBS)?
Avantis owns the most shares of Emergent Biosolutions (EBS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.